Salminen EK - Search Results

1

Estradiol and cognition during androgen deprivation in men with prostate carcinoma.

Salminen EK, Portin RI, Koskinen AI, Helenius HY, Nurmi MJ. Salminen EK, et al. Cancer. 2005 Apr 1;103(7):1381-7. doi: 10.1002/cncr.20962. Cancer. 2005. PMID: 15717315 Free article.

2

Prospective randomized trial of interferon alfa-2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancer.

Pyrhönen S, Salminen E, Ruutu M, Lehtonen T, Nurmi M, Tammela T, Juusela H, Rintala E, Hietanen P, Kellokumpu-Lehtinen PL. Pyrhönen S, et al. J Clin Oncol. 1999 Sep;17(9):2859-67. doi: 10.1200/JCO.1999.17.9.2859. J Clin Oncol. 1999. PMID: 10561363 Clinical Trial.

3

Impairment of heart rate variability during paclitaxel therapy.

Ekholm EM, Salminen EK, Huikuri HV, Jalonen J, Antila KJ, Salmi TA, Rantanen VT. Ekholm EM, et al. Among authors: salminen ek. Cancer. 2000 May 1;88(9):2149-53. doi: 10.1002/(sici)1097-0142(20000501)88:9<2149::aid-cncr22>3.0.co;2-z. Cancer. 2000. PMID: 10813728

4

Management of testicular cancer--16 years' experience from southwest Finland.

Sundström J, Salminen E, Nurmi M, Toppari J, Pöllänen P, Pelliniemi LJ, Huhtala S, Rajala P, Laato M. Sundström J, et al. Scand J Urol Nephrol. 2001 Feb;35(1):21-5. doi: 10.1080/00365590151030723. Scand J Urol Nephrol. 2001. PMID: 11291682

5

Short-term effects of radiotherapy on attention and memory performances in patients with brain tumors.

Lilja AM, Portin RI, Hämäläinen PI, Salminen EK. Lilja AM, et al. Among authors: salminen ek. Cancer. 2001 Jun 15;91(12):2361-8. Cancer. 2001. PMID: 11413526

6

Feasibility of prolonged use of interferon-alpha in metastatic kidney carcinoma: a phase II study.

Kankuri M, Pelliniemi TT, Pyrhönen S, Nikkanen V, Helenius H, Salminen E. Kankuri M, et al. Cancer. 2001 Aug 15;92(4):761-7. doi: 10.1002/1097-0142(20010815)92:4<761::aid-cncr1380>3.0.co;2-#. Cancer. 2001. PMID: 11550145 Clinical Trial.

7

Docetaxel with epirubicin--investigations on cardiac safety.

Salminen E, Syvänen K, Korpela J, Varpula M, Antila K, Varjo P, Ekholm E. Salminen E, et al. Anticancer Drugs. 2003 Jan;14(1):73-7. doi: 10.1097/00001813-200301000-00010. Anticancer Drugs. 2003. PMID: 12544261 Clinical Trial.

8

Low expression of p27 indicates a poor prognosis in patients with high-grade astrocytomas.

Kirla RM, Haapasalo HK, Kalimo H, Salminen EK. Kirla RM, et al. Among authors: salminen ek. Cancer. 2003 Feb 1;97(3):644-8. doi: 10.1002/cncr.11079. Cancer. 2003. PMID: 12548606 Free article.

9

Androgen deprivation and cognition in prostate cancer.

Salminen E, Portin R, Korpela J, Backman H, Parvinen LM, Helenius H, Nurmi M. Salminen E, et al. Br J Cancer. 2003 Sep 15;89(6):971-6. doi: 10.1038/sj.bjc.6601235. Br J Cancer. 2003. PMID: 12966411 Free PMC article.

10

Effect of adjuvant androgen deprivation on thyroid function tests in prostate cancer patients.

Salminen E, Koskinen A, Backman H, Nurmi M. Salminen E, et al. Anticancer Drugs. 2004 Apr;15(4):351-6. doi: 10.1097/00001813-200404000-00007. Anticancer Drugs. 2004. PMID: 15057139

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

151 results

Search Page